logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Alicia Okines

The Royal Marsden NHS Foundation Trust
H指数:41
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: a systematic literature review of real-world evidence

曲拉曲坦在HER2阳性晚期/转移性乳腺癌患者中的应用：一项真实世界证据的系统文献综述

The Breast
IF0
2026-06-090
OAAI
Rodrigo Sanchez-Bayona; Carey Anders; Rupert Bartsch; David A. Cameron; Eva M. Ciruelos; Carmen Criscitiello; Francois P. Duhoux; Theodoros Foukakis; Jean-Sebastien Frenel; Joseph Gligorov; Peter A. Kaufman; Matteo Lambertini; Nathalie LeVasseur; Alicia Okines; Frédérique Penault-Llorca; Volkmar Müller; Matthew T. Blahna; Edward Neuberger; Sofia Simon; Emanuele Zanucco
Efficacy and Safety of Oral Progestogens (Megestrol Acetate and Medroxyprogesterone Acetate) in Heavily Pretreated Oestrogen Receptor-Positive Metastatic Breast Cancer: A 10-Year Multi-Site Study

口服孕激素（Megestrol Acetate和Medroxyprogesterone Acetate）在重度预处理的雌激素受体阳性转移性乳腺癌中的疗效与安全性：一项为期10年的多中心研究

Cancers
IF4.4
2026-04-080
OA
Iseult M. Browne; Heng Chun Wong; Tazia Irfan; Chloe Chan; Stephen R. D. Johnston; Zoe Kemp; Emma Kipps; Marina Parton; Nicholas C. Turner; Alicia F. C. Okines
Clinicopathological features and outcomes of patients with adenoid cystic carcinoma of the breast in a large cancer institution: Retrospective analysis of 20 years of real-world experience

腺样囊性乳腺癌患者的临床病理特征和预后：基于大型癌症机构20年真实世界经验的回顾性分析

Clinical Oncology
IF3
2026-03-140
PRE
Susanna Slater; Myrto Kastrisiou; Mae Alghawas; Edward Phillips; Stephen Johnston; Zoe Kemp; Emma Kipps; Marina Parton; Nicholas Turner; Alicia Okines
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02

Tucatinib和trastuzumab emtansine用于既往治疗过的HER2阳性局部晚期和转移性乳腺癌患者：随机III期试验HER2CLIMB-02的主要分析

Annals of Oncology
IF65.4
2025-11-170
OAAI
S.A. Hurvitz; S. Loi; J. O’Shaughnessy; A.F.C. Okines; S.M. Tolaney; J. Sohn; C. Saura; X. Zhu; D. Cameron; T. Bachelot; E. Hamilton; G. Curigliano; A.C. Wolff; N. Harbeck; N. Masuda; L. Vahdat; K. Zaman; F. Valdes-Albini; M. Block; T. Pluard
Grade 3 and grade 4 cutaneous toxicities in patients with multiple solid tumour types receiving checkpoint inhibitor therapy: an observational study. The experience of a single large specialist institution

接受检查点抑制剂治疗的多发性实体瘤患者中3级和4级皮肤毒性的观察性研究：一家大型专科机构的经验

CLINICAL AND EXPERIMENTAL DERMATOLOGY
IF2.8
2025-04-170
PRE
Zaina Sharif; James Larkin; Lisa Pickering; Kate Young; Praveena Idaikkadar; Alicia Okines; Nadza Tokaca; Silvia Aguilar-Duran; Kara Heelan
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial

Tucatinib和trastuzumab在HER2突变转移性乳腺癌中的应用：一项II期篮式试验

NATURE MEDICINE
IF50
2025-01-170
OA
Okines, Alicia F. C.; Curigliano, Giuseppe; Oh, Do-Youn; Rorive, Andree; Takahashi, Shunji; Burkard, Mark E.; Chung, Ki Y.; Debruyne, Philip R.; Fox, Jenny R.; Gambardella, Valentina; Gil-Martin, Marta; Hamilton, Erika P.; Monk, Bradley J.; Nakamura, Yoshiaki; O'Malley, David M.; Olawaiye, Alexander B.; Pothuri, Bhavana; Reck, Martin; Sudo, Kazuki; Sunakawa, Yu; Van Marcke, Cedric; Yu, Evan Y.; Ramos, Jorge; Tan, Sherry; Bieda, Mark; Stinchcombe, Thomas E.; Pohlmann, Paula R.
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study
BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-05-141
PRE
Coriano, Matilde; Tommasi, Chiara; Dinh, Anh Thi Lan; Needham, Jazmine; Aziz, Hala; Joharatnam-Hogan, Nalinie; Cunningham, Niamh; Waterhouse, Jasmin; Sun, Mingze; Turkes, Fiona; Pellegrino, Benedetta; Mcgrath, Sophie; Okines, Alicia; Parton, Marina; Turner, Nicholas; Johnston, Stephen; Musolino, Antonino; Ring, Alistair; Battisti, Nicolo Matteo Luca
HER2CLIMB-02: Randomized, Double-Blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-Positive Metastatic Breast Cancer
CANCER RESEARCH
IF16.6
2024-05-026
PRE
Hurvitz, Sara; Loi, Sherene; O'Shaughnessy, Joyce; Okines, Alicia; Tolaney, Sara; Sohn, Joo Hyuk; Saura, Cristina; Zhu, Xiaofu; Cameron, David; Bachelot, Thomas; Hamilton, Erika; Curigliano, Giuseppe; Wolff, Antonio; Harbeck, Nadia; Masuda, Norikazu; Vahdat, Linda; Zaman, Khalil; Valdes-Albini, Frances; Block, Margaret; Pluard, Timothy; Tan, Tira; Gawryletz, Chelsea; Chan, Arlene; Bedard, Philippe; Yerushalmi, Rinat; Xu, Binghe; Tryfonidis, Konstantinos; Schmitt, Michael; Xie, Joan; Borges, Virginia
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom
BRITISH JOURNAL OF CANCER
IF6.8
2024-04-245
OA
Hanna, Daire; Merrick, Sophie; Ghose, Aruni; Devlin, Michael John; Yang, Dorothy D.; Phillips, Edward; Okines, Alicia; Chopra, Neha; Papadimatraki, Elisavet; Ross, Kirsty; Macpherson, Iain; Boh, Zhuang Y.; Michie, Caroline O.; Swampillai, Angela; Gupta, Sunnia; Robinson, Tim; Germain, Lewis; Twelves, Chris; Atkinson, Charlotte; Konstantis, Apostolos; Riddle, Pippa; Cresti, Nicola; Naik, Jay D.; Borley, Annabel; Guppy, Amy; Schmid, Peter; Phillips, Melissa
Tracking triple negative breast cancer (TNBC) evolution in the molecular residual disease (MRD) setting in the c-TRAK TN clinical trial
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Coakley, Maria; Cutts, Rosalind J.; Sritharan, Prithika; Hrebien, Sarah; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Villacampa, Guillermo; Rojas, Patricia; Emmett, Warren; Pipinikas, Christodoulos; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Bliss, Judith M.; Garcia-Murillas, Isaac; Turner, Nicholas C.
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis (vol 33, pg 321, 2022)
ANNALS OF ONCOLOGY
IF65.4
2023-07-012
OAAI
Curigliano, G.; Mueller, V.; Borges, V.; Hamilton, E.; Hurvitz, S.; Loi, S.; Murthy, R.; Okines, A.; Paplomata, E.; Cameron, D.; Carey, L. A.; Gelmon, K.; Hortobagyi, G. N.; Krop, I.; Loibl, S.; Pegram, M.; Slamon, D.; Ramos, J.; Feng, W.; Winer, E.
A randomised phase II trial of palbociclib and fulvestrant vs standard endocrine therapy in patients with ER positive HER2 negative breast cancer and ctDNA detected molecular relapse during adjuvant endocrine therapy (TRAK-ER)
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Turner, Nicholas; Phillips, Edward R.; Bunce, Catey; Robert, Marie; Bailleux, Caroline; Garcia-Murillas, Isaac; Khabra, Komel; Macpherson, Iain; O'Brien, Ciara S.; Okines, Alicia F.; Palmieri, Carlo; Schmid, Peter; Swift, Claire; Yara, Sabrina; Connolly, Simon; Lemonnier, Jerome; Lee, Dymphna; Andre, Fabrice
Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial
CANCER RESEARCH
IF16.6
2023-03-011
PRE
Coakley, Maria; Sritharan, Prithika; Villacampa, Guillermo; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Rojas, Patricia; Joad, Andy; Emmett, Warren; Knape, Charlene; Howarth, Karen; Hall, Peter S.; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia F.; Wardley, Andrew M.; Wheatley, Duncan; Waters, Simon; Cutts, Rosalind; Garcia-Murillas, Isaac; Bliss, Judith; Turner, Nicholas

研究方向

暂未获取到该数据
N
Nicholas C. Turner
H 指数:92论文数:1,157被引数:4.5万
D
David Cunningham
H 指数:153论文数:2,060被引数:13.0万
M
Marina Parton
H 指数:24论文数:149被引数:3,237
A
Alistair Ring
H 指数:36论文数:307被引数:5,677
I
Ian Chau
H 指数:81论文数:850被引数:4.5万
D
David Cameron
H 指数:108论文数:1,037被引数:6.6万
S
Stephen Johnston
H 指数:62论文数:480被引数:1.7万
G
Giuseppe Curigliano
H 指数:118论文数:1,729被引数:7.3万
E
Erika Hamilton
H 指数:58论文数:843被引数:1.6万
S
Sherene Loi
H 指数:126论文数:1,217被引数:7.8万